Biote (BTMD) Receivables (2021 - 2026)

Biote has reported Receivables for 6 years, with the latest figure at $7.4 million in Q1 2026.

• For the quarter ending Q1 2026, Receivables fell 4.74% year-over-year to $7.4 million; the trailing twelve-month figure through Mar 2026 stood at $7.4 million (down 4.74% YoY), and the FY2025 full-year result was $6.9 million, down 10.0% from the prior year.
• Receivables for Q1 2026 stood at $7.4 million, up from $6.9 million in the prior quarter.
• The five-year high for Receivables was $10.2 million in Q3 2023, with the low at $6.8 million in Q4 2023.
• Average Receivables over 5 years is $7.8 million, with a median of $7.7 million recorded in 2023.
• Year-over-year, Receivables soared 33.29% in 2023 and dropped 16.55% in 2024.
• Tracing BTMD's Receivables over 5 years: stood at $6.9 million in 2022, then decreased by 2.0% to $6.8 million in 2023, then rose by 12.07% to $7.6 million in 2024, then dropped by 10.0% to $6.9 million in 2025, then advanced by 7.7% to $7.4 million in 2026.
• The last three Receivables figures came in at $7.4 million (Q1 2026), $6.9 million (Q4 2025), and $8.0 million (Q3 2025), per Business Quant data.

Peer Comparison